secwatch.observer — SEC 8-K summary
======================================

Issuer:     Absci Corp (ABSI)
CIK:        0001672688
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001628280-23-029198
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Absci appoints new CFO; Q2 revenue up but net loss widens on $21.3M goodwill impairment
--------------------------------------------------------------------------------

- Zach Jonasson, Ph.D. named CFO and CBO effective Aug 31, 2023, replacing retiring CFO Greg Schiffman.
- Q2 revenue $3.4M vs $1.0M YoY; net loss $41.7M (incl. $21.3M goodwill impairment) vs $28.7M.
- Cash and equivalents $124.6M; expects cash runway into late 2025.
- Entered partnership with a Google Ventures-backed biotech; HIV vaccine collab with Caltech and Gates Foundation; completed Merck enzyme programs.
- Expects at least 10 new Active Programs in 2023; gross cash use projected ~$90M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672688/000162828023029198/0001628280-23-029198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672688/000162828023029198/absc-20230811.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-029198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer